Spectrophores as one-dimensional descriptors calculated from three-dimensional atomic properties: applications ranging from scaffold hopping to multi-target virtual screening

Spectrophores are novel descriptors that are calculated from the three-dimensional atomic properties of molecules. In our current implementation, the atomic properties that were used to calculate spectrophores include atomic partial charges, atomic lipophilicity indices, atomic shape deviations and atomic softness properties. This approach can easily be widened to also include additional atomic properties. Our novel methodology finds its roots in the experimental affinity fingerprinting technology developed in the 1990’s by Terrapin Technologies. Here we have translated it into a purely virtual approach using artificial affinity cages and a simplified metric to calculate the interaction between these cages and the atomic properties. A typical spectrophore consists of a vector of 48 real numbers. This makes it highly suitable for the calculation of a wide range of similarity measures for use in virtual screening and for the investigation of quantitative structure–activity relationships in combination with advanced statistical approaches such as self-organizing maps, support vector machines and neural networks. In our present report we demonstrate the applicability of our novel methodology for scaffold hopping as well as virtual screening.

[1]  Paul D Lyne,et al.  Structure-based virtual screening: an overview. , 2002, Drug discovery today.

[2]  Rafael Gozalbes,et al.  Small molecule databases and chemical descriptors useful in chemoinformatics: an overview. , 2011, Combinatorial chemistry & high throughput screening.

[3]  David A. Cosgrove,et al.  Lead Hopping Using SVM and 3D Pharmacophore Fingerprints , 2005, J. Chem. Inf. Model..

[4]  G. Maggiora,et al.  Molecular similarity in medicinal chemistry. , 2014, Journal of medicinal chemistry.

[5]  Sheng-Yong Yang,et al.  Pharmacophore modeling and applications in drug discovery: challenges and recent advances. , 2010, Drug discovery today.

[6]  Kam Y. J. Zhang,et al.  Pharmacophore modeling: advances, limitations, and current utility in drug discovery , 2014 .

[7]  Hugo Kubinyi,et al.  Similarity and Dissimilarity: A Medicinal Chemist’s View , 2002 .

[8]  Thomas Scior,et al.  Large compound databases for structure-activity relationships studies in drug discovery. , 2007, Mini reviews in medicinal chemistry.

[9]  Wannian Zhang,et al.  Fragment Informatics and Computational Fragment‐Based Drug Design: An Overview and Update , 2013, Medicinal research reviews.

[10]  B. Fan,et al.  Molecular similarity and diversity in chemoinformatics: From theory to applications , 2006, Molecular Diversity.

[11]  Joshi Sd,et al.  QSAR and 3D-QSAR in Drug Design Anti-Tubercular Drug DiscoveryStudies , 2016 .

[12]  Patrick Bultinck,et al.  Fast Calculation of Quantum Chemical Molecular Descriptors from the Electronegativity Equalization Method , 2003, J. Chem. Inf. Comput. Sci..

[13]  Peter Willett,et al.  Similarity searching using 2D structural fingerprints. , 2011, Methods in molecular biology.

[14]  Tomasz Arodz,et al.  Computational methods in developing quantitative structure-activity relationships (QSAR): a review. , 2006, Combinatorial chemistry & high throughput screening.

[15]  Andy Vinter,et al.  Molecular Field Extrema as Descriptors of Biological Activity: Definition and Validation , 2006, J. Chem. Inf. Model..

[16]  Jürgen Bajorath,et al.  Integration of virtual and high-throughput screening , 2002, Nature Reviews Drug Discovery.

[17]  Yanli Wang,et al.  PubChem: a public information system for analyzing bioactivities of small molecules , 2009, Nucleic Acids Res..

[18]  G. Klebe Virtual ligand screening: strategies, perspectives and limitations , 2006, Drug Discovery Today.

[19]  M. Mezei,et al.  Molecular docking: a powerful approach for structure-based drug discovery. , 2011, Current computer-aided drug design.

[20]  Malcolm J. McGregor,et al.  Pharmacophore Fingerprinting. 1. Application to QSAR and Focused Library Design , 1999, J. Chem. Inf. Comput. Sci..

[21]  Oleg Devinyak,et al.  3D-MoRSE descriptors explained. , 2014, Journal of molecular graphics & modelling.

[22]  P. Schreiner,et al.  Computational Chemistry: The Fate of Current Methods and Future Challenges. , 2018, Angewandte Chemie.

[23]  D. Behrens,et al.  Inhibition of dihydroorotate dehydrogenase activity by brequinar sodium. , 1992, Cancer research.

[24]  F. Bauss,et al.  BM 21.0955, a potent new bisphosphonate to inhibit bone resorption , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  Grover,et al.  Quantitative structure-property relationships in pharmaceutical research - Part 2. , 2000, Pharmaceutical science & technology today.

[26]  S. Pickett,et al.  GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors. , 2000, Journal of medicinal chemistry.

[27]  Peter Willett,et al.  Similarity-based virtual screening using 2D fingerprints. , 2006, Drug discovery today.

[28]  Michael M. Mysinger,et al.  Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking , 2012, Journal of medicinal chemistry.

[29]  D J Rogers,et al.  A Computer Program for Classifying Plants. , 1960, Science.

[30]  David Rogers,et al.  Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..

[31]  Gaël Varoquaux,et al.  Scikit-learn: Machine Learning in Python , 2011, J. Mach. Learn. Res..

[32]  Nam Doo Kim,et al.  Pharmacophore-based virtual screening: a review of recent applications , 2010, Expert opinion on drug discovery.

[33]  Singh,et al.  Quantitative structure-property relationships in pharmaceutical research - Part 1. , 2000, Pharmaceutical science & technology today.

[34]  Patrick Bultinck,et al.  The Electronegativity Equalization Method II: Applicability of Different Atomic Charge Schemes , 2002 .

[35]  Joel S. Freundlich,et al.  Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery. , 2011, Trends in Microbiology.

[36]  Subhash C Basak Mathematical descriptors for the prediction of property, bioactivity, and toxicity of chemicals from their structure: a chemical-cum-biochemical approach. , 2013, Current computer-aided drug design.

[37]  John M. Barnard,et al.  Chemical Fragment Generation and Clustering Software , 1997, J. Chem. Inf. Comput. Sci..

[38]  Klaus R. Liedl,et al.  One Concept, Three Implementations of 3D Pharmacophore-Based Virtual Screening: Distinct Coverage of Chemical Search Space , 2010, J. Chem. Inf. Model..

[39]  H. Kubinyi QSAR and 3D QSAR in drug design Part 1: methodology , 1997 .

[40]  John M. Barnard,et al.  Clustering Methods and Their Uses in Computational Chemistry , 2003 .

[41]  Yi Li,et al.  Analysis and optimization of structure-based virtual screening protocols. 2. Examination of docked ligand orientation sampling methodology: mapping a pharmacophore for success. , 2003, Journal of molecular graphics & modelling.

[42]  Sereina Riniker,et al.  Open-source platform to benchmark fingerprints for ligand-based virtual screening , 2013, Journal of Cheminformatics.

[43]  K. Baumann,et al.  Chemoinformatic Classification Methods and their Applicability Domain , 2016, Molecular informatics.

[44]  Péter Englert,et al.  Efficient Heuristics for Maximum Common Substructure Search , 2015, J. Chem. Inf. Model..

[45]  Malcolm J. McGregor,et al.  Pharmacophore Fingerprinting. 2. Application to Primary Library Design , 2000, J. Chem. Inf. Comput. Sci..

[46]  Harald Mauser,et al.  Database Clustering with a Combination of Fingerprint and Maximum Common Substructure Methods , 2005, J. Chem. Inf. Model..

[47]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[48]  Andreas Bender,et al.  Similarity Searching of Chemical Databases Using Atom Environment Descriptors (MOLPRINT 2D): Evaluation of Performance , 2004, J. Chem. Inf. Model..

[49]  J. Andrew Grant,et al.  Small Molecule Shape-Fingerprints , 2005, J. Chem. Inf. Model..

[50]  Qiang Zhang,et al.  Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring. , 2006, Journal of medicinal chemistry.

[51]  Adrià Cereto-Massagué,et al.  Molecular fingerprint similarity search in virtual screening. , 2015, Methods.

[52]  Oliver Koch,et al.  What Can We Learn from Bioactivity Data? Chemoinformatics Tools and Applications in Chemical Biology Research. , 2017, ACS chemical biology.

[53]  J. A. Grant,et al.  A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. , 2005, Journal of medicinal chemistry.

[54]  J. Irwin,et al.  Benchmarking sets for molecular docking. , 2006, Journal of medicinal chemistry.

[55]  David M. Rocke,et al.  Predicting ligand binding to proteins by affinity fingerprinting. , 1995, Chemistry & biology.